腎臓細胞がんにおける免疫療法
Miguel Zugman1, Salvador Jaime-Casas1, Peter D Zang1
1City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Cancer treatment and research
|August 23, 2025
まとめ
免疫チェックポイント阻害剤 (ICI) を含む免疫療法は,腎臓細胞癌 (RCC) の治療に変化をもたらし,持続的な反応をもたらしました. このレビューは,最先端のICI組み合わせ,補助療法,再挑戦戦略,および高度なRCCに対する新しいアプローチをカバーしています.
科学分野:
- 腫瘍学
- 免疫学
背景:
- 免疫療法は腎臓細胞癌 (RCC) の治療に革命を起こし,初期のサイトカインベースの治療から現在の免疫チェックポイント阻害剤 (ICI) の組み合わせへと進化しました.
- ICIベースの治療は,RCCの患者のアウトカムを著しく改善し,患者の一部に持続的な反応をもたらしました.
研究 の 目的:
- 転移性RCCの主要なICIベースの組み合わせをレビューする.
- 前回のICI曝露後の補助免疫療法と免疫療法の再挑戦に関する最近の進歩について議論します.
- チメリック抗原受容体 (CAR) T細胞療法および腸内微生物群介入を含む新興の免疫療法戦略を探求する.
主な方法:
- 転移性RCCにおける最前線ICI組み合わせに関する臨床試験データのレビュー
- 補助免疫療法と再挑戦治療に関する最近の研究の分析
- 新しい免疫療法戦略の探索と,RCCにおけるその潜在的な応用.
主要な成果:
- ICIベースの組み合わせは,第一線転移性RCCの設定において有意な有効性を示しています.
- 補助免疫療法と再挑戦戦略は 長期的な結果を改善する見込みを示しています
- CAR T細胞療法や微生物群の介入のような新興療法が RCC 免疫療法における将来の方向性を示しています
結論:
- 現在の免疫療法のアプローチ,特にICIの組み合わせは,進行したRCC患者の治療結果を顕著に改善しています.
- 将来の方向性には,新しい免疫療法方法に加えて,補助剤と再チャレンジ戦略の最適化が含まれています.
- 免疫関連の有害事象の管理と,進化するRCC治療の風景に細胞縮小性腎切除を統合するには,多学科的なアプローチが不可欠です.
さらに関連する動画
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.4K
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.7K
関連する概念動画
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
